New Report on Next Generation Sequencing In Clinical Applications

2013-07-16
Published : Jul-2013

Order “Next Generation Sequencing Emerging Clinical Applications and Global Markets″ report by calling ReportsnReports.com at +1 888 391 5441 OR send an email on [email protected] with Next Generation Sequencing Emerging Clinical Applications and Global Markets in subject line and your contact details.

ReportsnReports.com now offers “Next Generation Sequencing Emerging Clinical Applications and Global Markets” in its market research reports library.

BCC Research’s goal for this study is to provide an in-depth analysis of the clinical next generation sequencing (NGS) industry, an emerging industry with enormous market potential.  The approach of analyzing the industry is taken in terms of workflow (e.g., sequencers, sequence capture, informatics) and key indications where NGS diagnostics will have market share by 2018.

BCC Research examines the markets for NGS diagnostics for the years 2012, 2013 and 2018.

The global NGS diagnostic markets are characterized and quantified by disease indication, test complexity, test purpose and geography.

Market segments that provide exciting growth opportunities include cancer, rare genetic diseases and prenatal screening.

The report provides a comprehensive discussion of NGS technologies, clinical applications, industry structure, important clinical sequencing initiatives, global markets, patent status and companies. The report is designed to aid companies in their strategic planning efforts for clinical genetic testing.

Complete report spread across [195] pages @ http://www.reportsnreports.com/reports/265829-next-generation-sequencing-emerging-clinical-applications-and-global-markets.html. Read more on “Next Generation Sequencing Emerging Clinical Applications and Global Markets” report below.

This report provides:

  • An overview of the global market for next-generation sequencing and its emerging clinical applications
  • Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018
  • Examination of the sequencing industry structure for the key market segments, as well as strategic alliances and acquisitions, as well as evaluations of sequencing patents
  • Discussion of the strategies of the main companies in the market
  • Comprehensive company profiles of major players in the segment.

Request a Sample of this report by BCC Research @ http://www.reportsnreports.com/contacts/RequestSample.aspx?name=265829.

Company Profiles: 23andme Inc., Adaptive Biotechnologies Inc., Agilent Technologies Inc., Almac Group Ltd., Ambry Genetics, Appistry Inc., Arpeggi Inc., Astrid Bioscience Gmbh, Assurerx Health, Asuragen Inc., Base4innovation Ltd., Beckman Coulter, Berry Genomics Co. Ltd., Bgi, Bina Technologies Inc., Caris Life Sciences, Chronix Biomedical, Coriell Life Sciences Inc., Correlagen Diagnostics Inc., Counsyl Inc., Courtagen Life Sciences Inc., Cypher Genomics Inc., Cynvenio Biosystems Inc., Diogenix Inc., Dna Electronics Ltd., Dna Link, Dnanexus Inc., Electronic Biosciences, Eurofins Mwg Operon, Exosome Diagnostics Inc., Expression Analysis Inc., Foundation Medicine, Gatc Biotech Ag, Ge Healthcare, Genapsys, Gendx Bv, Genedx Inc., Genia Technologies Inc., Genologics Life Sciences Software, Genomatix Software Gmbh, Genomequest Inc., Genomic Health Inc., Gigagen Inc., Gnubio Inc., Good Start Genetics Inc., Illumina Inc., Innovations Exchange Pte Ltd, Ingenuity Systems Inc., Invitae, Irepertoire, Kailos Genetics, Kellbenx Inc., Knome Inc., Laboratory Corporation of America Inc., Laboratory For Molecular Medicine, Lasergen Inc., Life Technologies Inc., Lingvitae Holding As, Macrogen Inc., Maverix Biomics Inc., Md Anderson Cancer Center, Medgenome Labs Pvt. Ltd., Medomics Llc., Multiplicom Nv, Myriad Genetics Inc., Nabsys Inc., Natera Inc., Newgene Ltd., Noblegen Biosciences, Novartis Ag, Omicia Inc., Omixon Biocomputing Kft, Oncodna Sa, Oxford Gene Technology, Oxford Nanopore Technologies, Pacific Biosciences of California Inc., Parabase Genomics, Pathogenica, Pathogenetix, Perkin Elmer Inc.,Personal Genome Diagnostics Inc., Personalis Inc., Picoseq, Population Genetics Technologies Ltd., Portable Genomics Llc, Preventiongenetics Inc., Qiagen, Quantumdx, Raindance Technologies Inc., Real Time Genomics Inc., Response Genetics Inc., Roche Holding Ag, Scigenom Labs, Sengenics International Pte Ltd., Sequenom Inc., Sequenta Inc., Sequoia Genetics Co. Ltd., Seven Bridges Genomics Inc., Siemens Ag, Silicon Valley Biosystems, Sistemas Genomicos, , Softgenetics Llc, Station X Inc., Strand Life Sciences, Stratos Genomics Inc., Sundance Diagnostics Inc., Syapse, Thermo Fisher Scientific, Inc., Transgenomic Inc., Trovagene Inc., Warp Drive Bio Llc, Yikon Genomics Co. Ltd., Zs Genetics

Contact [email protected] / Call +1 888 391 5441 for further information on “Next Generation Sequencing Emerging Clinical Applications and Global Markets” report OR for any other market research and intelligence needs you may have for your business.

Filed in: Biotechnology
Tags: 
More Reports
Title Price Buy Now

Stem Cell Assays Market by Type (Viability, Proliferation, Differentiation, Apoptosis), Cell Type (Mesenchymal, iPSCs, HSCs, hESCs), Product & Service (Instrument), Application (Regenerative Medicine, Clinical Research), End User – Global Forecast to 2027

“The stem cell assays market growth can be attributed to factors such as the rising demand for technologically advanced stem cell analysis instruments, increase in the prevalence of cancer & other diseases and rising number of biopharma and & biotechnology companies working on stem cell based therapies.” The stem cell assays market is projected to reach USD 4.5 Billion by 2027 from USD 1.9 Billion in 2022, at a CAGR of 17.7% during the forecast period. The growth of the market is projected to be driven by collaborations and agreements among market players for stem cell assay products & services, launch of new stem cell analysis systems such as flow cytometers and increase in R&D expenditure by biopharmaceutical and biotechnology companies. The viability/cytotoxici......
 $

Nucleic Acid Isolation & Purification Market by Product (Kit, Reagent, Instrument), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA, miRNA), Application (Drug Discovery, Diagnostics), End User (Pharma, Biotech) – Global Forecast to 2027

The nucleic acid isolation and purification market is expected to grow at a CAGR of 7.9% in the forecast period. The global nucleic acid isolation and purification market is projected to reach USD 9.2 billion by 2027 from USD 6.3 billion in 2022, at a CAGR of 7.9% during the forecast period. The growth of this market can majorly be attributed to the increasing R&D activities as well as technological advancements and increasing automation. The emerging economies, improving regulatory and reimbursement scenario, and the growing adoption of molecular diagnostics and personalized medicines are expected to offer a wide range of growth opportunities for players in the market. However, the high cost of automated instruments is expected to hinder the growth of the market. As the world be......
 $4950

Wound Care Biologics Market by Product (Biological Skin Substitutes, Topical Agents), Wound Type (Ulcers [Diabetic Foot, Venous, Pressure Ulcers], Surgical & Traumatic Wounds, Burns), End User (Hospitals, ASCs, Burn Centers) – Global Forecast to 2027

“Rising number of road accidents and associated traumatic wounds and growing incidence of burn injuries are driving the overall growth of the wound care biologics market” The global wound care biologics market is valued at an estimated USD 1.8 billion in 2022 and is projected to reach USD 2.4 billion by 2027, at a CAGR of 5.4% during the forecast period. Market growth is driven by factors such as the growing incidence of burn injuries and the rising number of road accidents and associated traumatic wounds. However, the high cost of wound care biologic products and the risk associated with skin substitute failure are the major factors hampering the growth of this market. “The biological skin substitutes segment accounted for the highest growth rate in the wound care biologics ma......
 $4950

Bioanalytical Testing Services Market by Type, Application (Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology), End User and Region (North America, Europe, APAC, Latin America, MEA) – Global Forecast to 2027

“The global bioanalytical testing services market is projected to grow at a CAGR of 15.6%” Bioanalytical testing involves analytical methods used for the detailed examination of biological and biotechnology products. Bioanalysis enables the quantitative measurement of drugs and their metabolites, biological molecules in unnatural locations or concentrations, DNA, and large molecules. The global bioanalytical testing services market is projected to reach USD 6.0 billion by 2027 from an estimated USD 2.9 billion in 2022, at a CAGR of 15.6% during the forecast period. “The Cell-based assays segment is expected to account for the largest share of the bioanalytical testing services market” The increasing prevalence of chronic diseases and the rising number of clinical trials ar......
 $4950

Cell Analysis Market by Product & Service (Reagents & Consumables, Instruments), Technique (Flow Cytometry, High Content Screening), Process (Single-cell Analysis), End User (Pharmaceutical and Biotechnology Companies) – Global Forecast to 2027

“Single-cell analysis segment has gained significant traction in the recent years attributed to the widening applications of this technology in cancer research. This is further supplemented by the robust government initiatives targeted towards single-cell analysis research. The growth of the single-cell analysis segment is expected to drive the overall growth of the cell analysis market.” The global cell analysis market is projected to reach USD 28.6 Billion by 2027 from USD 17.7 Billion in 2022, at a CAGR of 10.1% during the forecast period. Key opportunities for the cell analysis market include, emerging economies, high risk of communicable diseases and pandemic outbreak, and increasing adoption of novel cellular assays in various cancer research applications. On the other hand, h......
 $4950

3D Cell Culture Market by Type (Hydrogel, ECM, Hanging Drop, Bioreactor, Microfluidics, Magnetic Levitation), Application (Cancer, Stem Cell, Toxicology, Tissue Engineering), End User (Pharma, Biotech, Research, Cosmetics), Region – Global Forecast to 2027

“Increasing focus on developing alternative methods to animal testing, growing focus on personalized medicine is driving the overall growth of the3D Cell culture market” The global 3D cell culture market is valued at an estimated USD 1.3 billion in 2022 and is projected to reach USD 2.6 billion by 2027, at a CAGR of 15.6% during the forecast period. The growth of this market is mainly driven by factors such as the increasing focus on developing alternative methods to animal testing, growing focus on personalized medicine, increasing incidence of chronic diseases, and the availability of funding for research. On the other hand, a lack of infrastructure for 3D cell-based research and the high cost of cell biology research are expected to restrain the growth of this market during the f......
 $4950

Tangential Flow Filtration Market by Product (System, Membrane Filter), Material (PES, PVDF, PTFE), Technique (Ultrafiltration), Application (Final Product Processing, Raw Material Filtration), End User (Pharma, Biotech), Region – Global Forecast to 2027

“Growth in the tangential flow filtration market can be attributed to factors such as the growing advantages of tangential flow filtration over normal flow filtration, rising R&D spending in pharmaceutical & biotechnology industries and increasing adoption of single-use technologies.” The global tangential flow filtration market is projected to USD 2.8 billion by 2027 from USD 1.5 billion in 2022, at a CAGR of 13.2% during the forecast period. The rising advantages of tangential flow filtration over normal flow filtration, increasing adoption of single-use technologies, and growing R&D spending in pharma-biotech companies. On the contrary, the high capital investments for setting up new production facilities are expected to restrain the market growth. “In 2021 the s......
 $4950

Human Microbiome Market by Product (Prebiotics, Probiotics, Food, Diagnostic Tests, Drugs), Application (Therapeutic, Diagnostic), Disease (Infectious, Metabolic/Endocrine), Research Technology (Genomics, Proteomics, Metabolomics) – Global Forecast to 2029

“Increased focus on human microbiome therapy development to drive the growth of this market.” The human microbiome market is projected to reach USD 1,370 million by 2029 from USD 269 million in 2023, at a CAGR of 31.1% from 2023 to 2029. The major factor driving the growth of the human microbiome market is the increasing focus on human microbiome therapy development. The human microbiome as a validated target for drug development & development of human microbiome-based tests for early disease detection and diagnosis are also factors expected to support market growth. However, a lack of expertise and inadequate research on the human microbiome are factors expected to restrain this market's growth. “By product segment, the drugs segment accounted for the largest share of huma......
 $4950

Exosome Research Market by Product and services (Kits, Reagents, Instrument), Indication (Cancer, Infectious Diseases), Application (Biomarkers, Vaccines), Manufacturing Services (Stem cell, Dendritic cell-derived), End User – Global Forecast to 2026

“Increasing interest in exosome-based proceduresto Drive the Growth of Market” The exosome research market is valued at an estimated USD 144 million in 2021 and is projected to reach USD 661 million by 2026, at a CAGR of 35.6% during the forecast period, owing to increased funding for life sciences research, the high global prevalence of cancer, and the increasing interest in exosome-based procedures. “By product & service, the kits & reagents segment accounted for the largest share of the exosome research market” Based on product and service, the exosomes market is segmented into kits & reagents, instruments, and services. The kits & reagents segment is further divided into antibodies, isolation, purification, quantitation kits & reagents, and other ki......
 $4950

Metagenomic Sequencing Market by Product & Services (Reagent, Consumables, Instrument), Workflow (Sample Preparation, Sequencing), Technology (16S rRNA, Shotgun, Whole-genome), Application (Drug Discovery, Diagnostic) – Global Forecast to 2027

“Continuous technological innovations in NGS platforms is the key factors driving growth in the metagenomic sequencing market’’ The metagenomic sequencing market is expected to reach USD 4.3 billion by 2027 from USD 1.9 billion in 2022, at a CAGR of 18.4% during the forecast period. Growth in the metagenomic sequencing market is mainly driven by continuous technological innovations in NGS platforms, increasing initiatives and funding from government & private bodies for large-scale sequencing projects, declining costs of genome sequencing, and the significant applications of metagenomics in various fields. “By technology segment, the shotgun metagenomic sequencing segment accounted for the fastest-growing segment of the metagenomic sequencing market” Based on technol......
 $4950
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy